![tert-butyl (4R,6R)-2-[[[6-(2-4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxan-4-yl]acetate](https://www.chemshuttle.com/media/catalog/product/cache/31dbf0bffbfa69a5826a72cec9a446de/1/0/109978_2.jpg)
N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide
$300.00
CAS No.: 137973-76-3
Catalog No.: 109979
Purity: 95%
MF: C26H23ClN2O3
MW: 446.934
Storage: 2-8 degree Celsius
SMILES: CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2CCCC(=O)C3=CC(Cl)=CC=C23)C(C)=C1
Catalog No.: 109979
Purity: 95%
MF: C26H23ClN2O3
MW: 446.934
Storage: 2-8 degree Celsius
SMILES: CC1=CC=CC=C1C(=O)NC1=CC=C(C(=O)N2CCCC(=O)C3=CC(Cl)=CC=C23)C(C)=C1
N-[4-[(7-chloro-2,3,4,5-tetrahydro-5-oxo-1H-1-benzazepin-1-yl)carbonyl]-3-methylphenyl]-2-methylbenzamide; CAS No.: 137973-76-3; This tetrahydrobenzazepinone derivative exemplifies ChemShuttle s heterocycles expertise for vasopressin antagonist research. The 7-chloro substituent and tetrahydroazepine ring confer oral bioavailability. Our Friedel-Crafts alkylation achieves regioselective ring closure. The product serves as a lead compound for aquaretic agent development with reduced electrolyte imbalance risks.
Reviews
Write Your Own Review